File(s) under permanent embargo

Reason: Under embargo until October 2024. After this date a copy can be supplied under Section 51(2) of the Australian Copyright Act 1968 by submitting a document delivery request through your library, or by emailing

Fragment-Based Drug Design of Novel HIV-1 Reverse Transcriptase Inhibitors

posted on 13.10.2021, 00:12 by SHANE LILLIS DAWSON
HIV-1 reverse transcriptase (RT) inhibitors are critical components of antiretroviral therapy (ART) regimens used to control viral load in HIV patients. Previous work identified multiple inhibitory fragments of HIV-RT that bind to a novel allosteric pocket and possess a mechanism of action distinct from that of currently available drugs. This thesis builds upon these studies and applies a fragment-based drug design approach to systematically develop hit compounds into potent inhibitors. Over 120 purified and 180 unpurified compounds were evaluated. Additionally, this thesis describes mutagenesis studies used to assess a possible binding site of these inhibitors.


Campus location


Principal supervisor

David Chalmers

Additional supervisor 1

Philip Thompson

Additional supervisor 2

Gilda Tachedjian

Year of Award


Department, School or Centre

Medicinal Chemistry


Doctor of Philosophy

Degree Type



Faculty of Pharmacy and Pharmaceutical Sciences

Usage metrics